PE20090070A1 - Derivados de furano como agentes antiinfecciosos - Google Patents

Derivados de furano como agentes antiinfecciosos

Info

Publication number
PE20090070A1
PE20090070A1 PE2008000274A PE2008000274A PE20090070A1 PE 20090070 A1 PE20090070 A1 PE 20090070A1 PE 2008000274 A PE2008000274 A PE 2008000274A PE 2008000274 A PE2008000274 A PE 2008000274A PE 20090070 A1 PE20090070 A1 PE 20090070A1
Authority
PE
Peru
Prior art keywords
ethinyl
pyrimidin
furan
tetrahydro
diol
Prior art date
Application number
PE2008000274A
Other languages
English (en)
Spanish (es)
Inventor
Zheng Yin
Jeyaraj Duraiswamy
Yen Liang Chen
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39462074&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20090070(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PE20090070A1 publication Critical patent/PE20090070A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PE2008000274A 2007-02-09 2008-02-07 Derivados de furano como agentes antiinfecciosos PE20090070A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07102027 2007-02-09
EP08150003 2008-01-02

Publications (1)

Publication Number Publication Date
PE20090070A1 true PE20090070A1 (es) 2009-03-19

Family

ID=39462074

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008000274A PE20090070A1 (es) 2007-02-09 2008-02-07 Derivados de furano como agentes antiinfecciosos

Country Status (18)

Country Link
US (1) US8278282B2 (cg-RX-API-DMAC7.html)
EP (1) EP2132216B1 (cg-RX-API-DMAC7.html)
JP (1) JP2010518047A (cg-RX-API-DMAC7.html)
KR (1) KR20090109102A (cg-RX-API-DMAC7.html)
CN (1) CN101600726B (cg-RX-API-DMAC7.html)
AR (1) AR065249A1 (cg-RX-API-DMAC7.html)
AT (1) ATE533774T1 (cg-RX-API-DMAC7.html)
AU (1) AU2008212752A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0807222A2 (cg-RX-API-DMAC7.html)
CA (1) CA2675462A1 (cg-RX-API-DMAC7.html)
CL (1) CL2008000409A1 (cg-RX-API-DMAC7.html)
EA (1) EA200901080A1 (cg-RX-API-DMAC7.html)
ES (1) ES2381093T3 (cg-RX-API-DMAC7.html)
MX (1) MX2009008495A (cg-RX-API-DMAC7.html)
PE (1) PE20090070A1 (cg-RX-API-DMAC7.html)
PT (1) PT2132216E (cg-RX-API-DMAC7.html)
TW (1) TW200838550A (cg-RX-API-DMAC7.html)
WO (1) WO2008095993A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010015643A1 (en) * 2008-08-06 2010-02-11 Novartis Ag New antiviral modified nucleosides
CN102526087B (zh) * 2010-12-30 2014-09-03 南开大学 核苷类化合物在制备治疗肠病毒71(ev71)感染疾病药物的应用
CN105669783B (zh) * 2014-12-03 2019-11-12 广东东阳光药业有限公司 一种制备呋喃糖的方法
JP2018523665A (ja) 2015-08-06 2018-08-23 キメリックス インコーポレイテッド 抗ウイルス剤として有用なピロロピリミジンヌクレオシドおよびその類縁体
RU2720811C2 (ru) 2015-09-23 2020-05-13 Мерк Шарп И Доум Лимитед 4'-замещенные нуклеозидные ингибиторы обратной транскриптазы и их получение
EA201892448A1 (ru) * 2016-04-28 2019-06-28 Эмори Юниверсити Алкинсодержащие нуклеотидные и нуклеозидные терапевтические композиции и связанные с ними способы применения
TW201815821A (zh) * 2016-07-18 2018-05-01 美商再生元醫藥公司 抗茲卡病毒抗體及使用方法
TW201811339A (zh) * 2016-08-12 2018-04-01 美商艾洛斯生物製藥公司 經取代之核苷、核苷酸及其類似物
EP3684771B1 (en) 2017-09-21 2024-11-27 Chimerix, Inc. Morphic forms of 4-amino-7-(3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-methyl-7h-pyrrolo(2,3-d)pyrimidine-5-carboxamide and uses thereof
US11718534B2 (en) 2019-04-23 2023-08-08 Elementis Specialties, Inc. Slurry compositions containing mixed branched alkyl organoclay compositions
US20250057849A1 (en) * 2021-12-22 2025-02-20 Cj Cheiljedang Corporation Antiviral composition comprising nucleoside analogues derived from nucleic acid and pharmaceutically acceptable salt thereof
CN117430571B (zh) * 2022-07-15 2025-08-29 宜昌东阳光长江药业股份有限公司 一种制备吡喃葡萄糖基衍生物的关键中间体及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0206614A (pt) * 2001-01-22 2004-02-17 Merck & Co Inc Composto, composição farmacêutica, método para inibir a polimerase viral de rna dependente de rna e/ou inibir a replicação viral de rna dependente de rna, método para tratar uma infecção viral de rna dependente de rna, e, uso de um composto
JP2005511764A (ja) * 2001-12-14 2005-04-28 アルコン，インコーポレイテッド 緑内障の処置のためのアミノアルキルベンゾフラン−５−オール化合物
JP2005527499A (ja) * 2002-02-13 2005-09-15 メルク　エンド　カムパニー　インコーポレーテッド ヌクレオシド化合物を用いてオルトポックスウイルスの複製を阻害する方法
MXPA04010983A (es) * 2002-05-06 2005-02-14 Genelabs Tech Inc Derivados de nucleosidos para tratar infecciones por el virus de la hepatitis c.
TW200418498A (en) * 2002-09-30 2004-10-01 Genelabs Tech Inc Nucleoside derivatives for treating hepatitis C virus infection
US20040259934A1 (en) * 2003-05-01 2004-12-23 Olsen David B. Inhibiting Coronaviridae viral replication and treating Coronaviridae viral infection with nucleoside compounds
WO2005042556A1 (en) * 2003-10-27 2005-05-12 Genelabs Technologies, Inc. Nucleoside compounds for treating viral infections

Also Published As

Publication number Publication date
CA2675462A1 (en) 2008-08-14
CL2008000409A1 (es) 2008-08-29
ES2381093T3 (es) 2012-05-23
WO2008095993A1 (en) 2008-08-14
AU2008212752A1 (en) 2008-08-14
BRPI0807222A2 (pt) 2014-04-29
JP2010518047A (ja) 2010-05-27
ATE533774T1 (de) 2011-12-15
US20100227833A1 (en) 2010-09-09
CN101600726A (zh) 2009-12-09
EP2132216A1 (en) 2009-12-16
EP2132216B1 (en) 2011-11-16
AR065249A1 (es) 2009-05-27
MX2009008495A (es) 2009-08-20
PT2132216E (pt) 2012-02-20
KR20090109102A (ko) 2009-10-19
US8278282B2 (en) 2012-10-02
TW200838550A (en) 2008-10-01
CN101600726B (zh) 2013-03-27
EA200901080A1 (ru) 2010-02-26

Similar Documents

Publication Publication Date Title
PE20090070A1 (es) Derivados de furano como agentes antiinfecciosos
PE20090365A1 (es) Imidazopirazinas como inhibidores de proteina quinasa
PE20090648A1 (es) Compuestos para el tratamiento de la hepatitis c
PE20090326A1 (es) Compuestos heterociclos como inhibidores de erk
PE20061436A1 (es) Derivados de amida sustituida como inhibidores de proteina quinasa
PE20090511A1 (es) Imidazopiridinonas
PE20080704A1 (es) Inhibidores ns5b del virus hepatitis c de indolobenzazepina fusionados a ciclopropilo
PE20060837A1 (es) COMPUESTOS DE 3H-OXAZOLO Y 3H-TIAZOLO[4,5-d]PIRIMIDIN-2-ONA 3,5-DISUSTITUIDA Y 3,5,7-TRISUSTITUIDA Y PROFARMACOS DE LOS MISMOS
PE20171341A1 (es) Compuestos de pirazina para el tratamiento de enfermedades infecciosas
PE20050462A1 (es) COMPUESTOS DE 5,7-DIAMINOPIRAZOLO[4,3-d]PIRIMIDINAS COMO INHIBIDORES DE LA FOSFODIESTERASA TIPO 5 (PDE-5)
PE20120013A1 (es) Fosforamidato derivados de guanosina compuestos nucleosidos para tratamiento de infecciones virales
PE20171449A1 (es) Derivados de nucleosidos sustituidos utiles como agentes antineoplasicos
ECSP099319A (es) Analogos de tiofeno para el tratamiento o prevencion de las infecciones por flavivirus
SV2006002110A (es) Compuestos terapeuticos ref. pc32293a
PE20110833A1 (es) Nuevas octahidrociclopenta[c]pirrol-4-aminas sustituidas como bloqueantes de los canales de calcio
PE20110383A1 (es) Pirazolopirimidinonas como inhibidores de la fosfodiesterasa 9a (pde9a)
PE20091734A1 (es) Compuestos de 2-imino-3-metilpirrolopirimidinona fenilo-sustituida como inhibidores de bace-1, composiciones y su uso
CR20110620A (es) Derivados de n-(hetero)aril-pirrolidina de pirazo-4-il-pirrolo[2,3-d]pirimidinas y pirrol-3-il-pirrolo[2,3-d]pirimidinas como ihnibidores de la quinasa janus
UY29458A1 (es) Heterociclos sustituidos y usos de los mismos
PE20141681A1 (es) Inhibidores de btk
PE20091424A1 (es) Nucleosidos 2',4'-sustituidos como agentes antivirales
AR080233A1 (es) Derivados de dihidrofurano como compuestos insecticidas
UY33097A (es) DERIVADOS DE (1h-PIRAZOL-5-IL)UREIDOARILO 1,3-DISUSTITUIDOS Y SUS USOS TERAPÉUTICOS
PE20121010A1 (es) Derivados de bencimidazol
CR8249A (es) Forma cristalina gamma del clorhidrato de ivabradina, su procedimiento de preparacion y composiciones farmaceuticas que lo contienen

Legal Events

Date Code Title Description
FD Application declared void or lapsed